![Cyrus Harmon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cyrus Harmon
Fondatore presso
OLEMA PHARMACEUTICALS, INC.
Patrimonio netto: 11 M $ in data 31/05/2026
Profilo
Cyrus L.
Harmon was the founder of Neomorphics, Inc., founded in 1996, where the title held was Chief Executive Officer from 1996 to 2000.
Dr. Harmon is the founder of Olema Pharmaceuticals, Inc., founded in 2006, holding the title of Independent Director.
Dr. Harmon currently works at Vilya, Inc. as President & Chief Executive Officer since 2023.
Formerly, Dr. Harmon was General Manager at Affymetrix, Inc. from 2000 to 2002.
Education includes undergraduate and doctorate degrees from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/06/2026 | 844.798 ( 0,97% ) | 11 M $ | 31/05/2026 |
Posizioni attive di Cyrus Harmon
| Società | Posizione | Inizio |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Fondatore | 07/08/2006 |
Vilya Inc.
 Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Amministratore Delegato | 01/10/2023 |
Precedenti posizioni note di Cyrus Harmon
| Società | Posizione | Fine |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/01/2002 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Amministratore Delegato | 01/01/2000 |
Formazione di Cyrus Harmon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
